These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7422672)

  • 1. Analysis of the geometry of myocardial infarct size reduction with hyaluronidase.
    Kloner RA; Maroko PR; Braunwald E
    Proc Soc Exp Biol Med; 1980 Oct; 165(1):141-6. PubMed ID: 7422672
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of hyaluronidase and hydrocortisone in the reduction of myocardial infarct size following coronary occlusion. Experimental and clinical observations.
    Braunwald E; Maroko PR
    Acta Med Scand Suppl; 1976; 587():169-76. PubMed ID: 1062125
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term preservation of ischemic myocardium in the dog by hyaluronidase.
    Kloner RA; Braunwald E; Maroko PR
    Circulation; 1978 Aug; 58(2):220-6. PubMed ID: 668070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of hyaluronidase on morphological changes in the myocardium in experimental myocardial infarct].
    Afonskaia NI; Cherpachenko NM; Zhdanov VS
    Kardiologiia; 1979 Jan; 19(1):103-7. PubMed ID: 439587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronidase-induced reductions in myocardial infarct size.
    Maclean D; Fishbein MC; Maroko PR; Braunwald E
    Science; 1976 Oct; 194(4261):199-200. PubMed ID: 959848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electron-microscopic study of changes in the myocyte ultrastructure under the effect of hyaluronidase in experimental myocardial infarct].
    Afonskaia NI; Sharov VG; Nikolaeva LF
    Kardiologiia; 1977 Aug; 17(8):114-8. PubMed ID: 926553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hyaluronidase on the interrelations of the stromal elements of the myocardium in the healing of experimental myocardial infarct].
    Stavitskiĭ IuL
    Vrach Delo; 1985 Aug; (8):14-6. PubMed ID: 4072103
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous hyaluronidase therapy for myocardial infarction in man: double-blind trial to assess infarct size limitation.
    Cairns JA; Holder DA; Tanser P; Missirlis E
    Circulation; 1982 Apr; 65(4):764-71. PubMed ID: 7060255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS).
    Roberts R; Braunwald E; Muller JE; Croft C; Gold HK; Hartwell TD; Jaffe AS; Mullin SM; Parker C; Passamani ER
    Br Heart J; 1988 Oct; 60(4):290-8. PubMed ID: 3056476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a highly purified hyaluronidase preparation on experimental myocardial infarction in the rat.
    Nilsson JE; Sjögren C; Säwe U
    Acta Med Scand; 1984; 216(2):209-13. PubMed ID: 6496178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active drainage of cardiac lymph in relation to reduction in size of myocardial infarction: an experimental study.
    Taira A; Uehara K; Fukuda S; Takenada K; Koga M
    Angiology; 1990 Dec; 41(12):1029-36. PubMed ID: 2278398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of early administration of a highly purified hyaluronidase preparation (GL enzyme) on myocardial infarct size.
    Saltissi S; Robinson PS; Coltart DJ; Webb-Peploe MM; Croft DN
    Lancet; 1982 Apr; 1(8277):867-71. PubMed ID: 6122098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of beta-adrenergic inhibition on scar formation after myocardial infarction.
    Ravindranathan MP; Jenkins B; Haider B; Regan TJ
    Am Heart J; 1984 Jul; 108(1):25-30. PubMed ID: 6145352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing of myocardial infarcts in dogs. Effects of late reperfusion.
    Richard V; Murry CE; Reimer KA
    Circulation; 1995 Oct; 92(7):1891-901. PubMed ID: 7671374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion.
    Maroko PR; Libby P; Bloor CM; Sobel BE; Braunwald E
    Circulation; 1972 Sep; 46(3):430-7. PubMed ID: 5071733
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
    Maroko PR; Braunwald E
    Circulation; 1976 Mar; 53(3 Suppl):I162-8. PubMed ID: 767015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hyaluronidase and hydrocortisone on myocardial necrosis after coronary occlusion.
    Braunwald E; Maroko PR
    Am J Cardiol; 1976 Mar; 37(4):550-6. PubMed ID: 1258792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial infarction treated with two lymphagogues, calcium dobesilate (CLS 2210) and hyaluronidase: a coded, placebo-controlled animal study.
    Repa I; Garnic JD; Hollenberg NK
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):286-91. PubMed ID: 1697385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of myocardial infarction size after coronary occlusion.
    Maroko PR; Braunwald E
    Ann Intern Med; 1973 Nov; 79(5):720-33. PubMed ID: 4148053
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of hyaluronidase in acute myocardial infarction.
    Papa LA; Fitzgerald DL; Kauffman JM; Schiff S; Daly SJ; Hurwitz H; Caruso JW; Lowney JD; Corbally F
    J Am Osteopath Assoc; 1983 Oct; 83(2):128-32. PubMed ID: 6358150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.